Motilal Oswal BSE Healthcare ETF-Growth
Equity
Sectoral-Pharma
₹-0.05% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
Not Rated - Minimum Investment₹500
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹45 Cr
- Created on5 July 2022
Fund Ranking
#3
/ 16 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month17.5%
- 1 Year17.6%
- 3 Year (CAGR)23.0%
- All Time (CAGR)21.8%
Category Return
- 6 Month16.8%
- 1 Year18.1%
- 3 Year (CAGR)21.8%
- All Time (CAGR)17.2%
Asset Allocation
- Equity99.7%
- Other0.3%
Top 5 Holdings
Top 5 Sectors
- Aarti Drugs0.09%
- Anuh Pharma0.01%
- Apollo Hospitals Enterprise5.67%
- Astrazeneca Pharma India0.31%
- Aurobindo Pharma2.73%
Fund Information
- Expense Ratio0.36%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Managed By
Swapnil P Mayekar
July 2022 - Present
Rakesh Shetty
Nov 2022 - Present
Dishant Mehta
Oct 2024 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.02 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 16.28 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -0.23 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 1.00